Amniotics

Amniotics is a biopharmaceutical company created to facilitate the translation of stem cells into transformative medicines with the potential to cure serious human diseases.

Amniotics

CEO:

Kåre Engkilde

First investment year:

2019

Business sector:

Life Science, Medtech

Investment manager: Per Antonsson Visit website